Lieu, Tracy A.; Ortega-Sanchez, Ismael; Ray, G. Thomas; … - In: PharmacoEconomics 26 (2008) 3, pp. 235-249
Objectives: The US Advisory Committee on Immunization Practices has recently recommended a new vaccine against herpes zoster (shingles) for routine use in adults aged =60 years. However, estimates of the cost effectiveness of this vaccine vary widely, in part because of gaps in the data on the...